Game Plan Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1K Buy
+23
New +$988 ﹤0.01% 347
2025
Q4
Sell
-100
Closed -$5.55K 377
2025
Q3
$5.55K Hold
100
﹤0.01% 243
2025
Q2
$6.9K Hold
100
﹤0.01% 236
2025
Q1
$6.94K Hold
100
﹤0.01% 236
2024
Q4
$8.56K Sell
100
-447
-82% -$48.3K ﹤0.01% 236
2024
Q3
$65.1K Hold
547
0.03% 137
2024
Q2
$78.1K Hold
547
0.04% 133
2024
Q1
$70.2K Buy
547
+197
+56% +$23.5K 0.04% 142
2023
Q4
$36.2K Buy
+350
New +$34.6K 0.02% 164

Other funds holding NVO

Game Plan Financial Advisors's NVO Position: Q2 2026 in Review

Game Plan Financial Advisors opened a new position in Novo Nordisk (NVO) in Q2 2026: 23 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #347 among its holdings. This is a return to the name: Game Plan Financial Advisors previously reported a position in NVO as recently as Q3 2025.

Game Plan Financial Advisors first reported a position in NVO in Q4 2023 and has held it in 9 quarters since. The position peaked at $78.1K in Q2 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Game Plan Financial Advisors held 23 shares of Novo Nordisk worth $1.1K as of Q2 2026.
  • Novo Nordisk was a new Game Plan Financial Advisors position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Game Plan Financial Advisors's portfolio in Q2 2026, its #347 holding.
  • Game Plan Financial Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 9 quarters since.
  • Game Plan Financial Advisors's Novo Nordisk position peaked at $78.1K in Q2 2024.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Game Plan Financial Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.